Unknown

Dataset Information

0

Discovery of SARS-CoV-2 main protease covalent inhibitors from a DNA-encoded library selection.


ABSTRACT: Covalent inhibitors targeting the main protease (Mpro, or 3CLpro) of SARS-CoV-2 have shown promise in preclinical investigations. Herein, we report the discovery of two new series of molecules that irreversibly bind to SARS-CoV-2 Mpro. These acrylamide containing molecules were discovered using our covalent DNA-encoded library (DEL) screening platform. Following selection against SARS-CoV-2 Mpro, off-DNA compounds were synthesized and investigated to determine their inhibitory effects, the nature of their binding, and to generate preliminary structure-activity relationships. LC-MS analysis indicates a 1:1 (covalent) binding stoichiometry between our hit molecules and SARS-CoV-2 Mpro. Fluorescent staining assay for covalent binding in the presence of cell lysate suggests reasonable selectivity for SARS-CoV-2 Mpro. And lastly, inhibition of enzymatic activity was also observed against a panel of 3CLpro enzymes from different coronavirus strains, with IC50 values ranging from inactive to single digit micromolar. Our results indicate that DEL selection is a useful approach for identifying covalent inhibitors of cysteine proteases.

SUBMITTER: Ge R 

PROVIDER: S-EPMC8767972 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC10364469 | biostudies-literature
| S-EPMC10403511 | biostudies-literature
| S-EPMC8029447 | biostudies-literature
| S-EPMC8672434 | biostudies-literature
| S-EPMC8436407 | biostudies-literature
| S-EPMC8491550 | biostudies-literature
| S-EPMC7449189 | biostudies-literature
| S-EPMC7724992 | biostudies-literature
| S-EPMC9225965 | biostudies-literature
| S-EPMC10383128 | biostudies-literature